UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063645
Receipt number R000072741
Scientific Title A Virtual Reality-Based Mindfulness Program for Adults Aged 60 Years and Older
Date of disclosure of the study information 2026/11/16
Last modified on 2026/11/16 15:03:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Virtual Reality-Based Mindfulness Program for Adults Aged 60 Years and Older

Acronym

VR-MIND60

Scientific Title

A Virtual Reality-Based Mindfulness Program for Adults Aged 60 Years and Older

Scientific Title:Acronym

VR-MIND60

Region

Japan


Condition

Condition

Community-dwelling adults aged 60 years and older

Classification by specialty

Nursing Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this pilot study is to explore the feasibility and potential effects of a virtual reality (VR)-based mindfulness intervention among community-dwelling adults aged 60 years and older. The study seeks to provide preliminary evidence to inform the design of a future larger-scale trial.

Basic objectives2

Others

Basic objectives -Others

Feasibility and preliminary effects of a virtual reality-based mindfulness intervention.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Feasibility of the four-week VR-based mindfulness intervention, assessed through participation rates, dropout rates, and technical issues recorded during Weeks 1-4. Additional primary outcomes include usability assessed using the System Usability Scale (SUS), satisfaction assessed using the Japanese version of the Client Satisfaction Questionnaire (CSQ-8J), and sense of presence assessed using the Igroup Presence Questionnaire (IPQ; VR group only). SUS, CSQ-8J, and IPQ will be administered only at the end of Week 4, following completion of the intervention.

Key secondary outcomes

Changes in perceived stress (PSS), state anxiety (STAI-S), psychological well-being (WHO-5), and dispositional mindfulness (MAAS), assessed at baseline and after the four-week intervention.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Participants in the intervention group (n=15) will receive a virtual reality-based mindfulness program using a VR headset. The intervention consists of four sessions delivered once weekly over four weeks, approximately 15 minutes per session. Participants will individually view immersive 360-degree nature videos incorporating mindfulness guidance on awareness of pleasant experiences, bodily sensations, acceptance of difficult experiences, and compassion. Each session will be conducted in a quiet and safe environment under researcher supervision.

Interventions/Control_2

Participants in the control group (n=15) will receive the same mindfulness program through a conventional television display without a VR headset. The intervention consists of four sessions delivered once weekly over four weeks, approximately 15 minutes per session. Participants will view the same nature-based mindfulness content in small groups of approximately eight people, under researcher supervision.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Adults aged 60 years or older.
2. Able to use virtual reality equipment and attend the study site.
3. Able to participate in all intervention sessions.
4. Able to read and write Japanese.
5. Able and willing to provide voluntary informed consent to participate in the study.

Key exclusion criteria

1. Diagnosis of a neurological or psychiatric disorder associated with cognitive impairment.
2. Severe visual or hearing impairment.
3. Physical limitations that prevent the use of virtual reality equipment.
4. History of motion sickness or simulator sickness.
5. Regular mindfulness practice of one hour or more per week.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Noriko
Middle name
Last name Yamamoto-Mitani

Organization

The University of Tokyo

Division name

Department of Gerontological Home Care and Long-term Care Nursing, Graduate School of Medicine

Zip code

113-0033

Address

208 Faculty of Medicine Bldg. 5, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-5841-3508

Email

noriko-tky@g.ecc.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Ryousuke
Middle name
Last name Yamada

Organization

The University of Tokyo

Division name

Gerontological Home Care and Long-term Care Nursing, Graduate School of Medicine

Zip code

113-0033

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-5841-3508

Homepage URL


Email

yamada-ryousuke-2@g.ecc.u-tokyo.ac.jp


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

The Scientific and Technological Research Council of Turkiye

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization

Turkiye


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo

Address

Faculty of Medicine Building 2, 4th Floor, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan

Tel

03-5841-0818

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

The University of Tokyo, Graduate School of Medicine (Tokyo, Japan)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 10 Month 20 Day

Date of IRB

2026 Year 11 Month 13 Day

Anticipated trial start date

2026 Year 12 Month 01 Day

Last follow-up date

2027 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 16 Day

Last modified on

2026 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072741